Lexeo Therapeutics Total Liabilities

Lexeo Therapeutics (LXEO) currently reports a total liabilities of $19M as of March 2026. That compares with $38M in the prior-year period — down 49.8% year over year. Use the charts on this page to explore Lexeo Therapeutics's total liabilities history and peer comparisons.

Lexeo Therapeutics's total liabilities decreased from $38M to $19M — a 49.8% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Lexeo Therapeutics reported $19M in total liabilities as of March 2026. That compares with $38M in the prior-year period — down 49.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $19M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Lexeo Therapeutics, and consider following LXEO for alerts when major investors trade the stock.